Clinical trial
A Single-arm Study Evaluating the Efficacy and Safety of FLEXIPORT, a Single-incision Totally Implantable Venous Access Device, in Patients Receiving Chemotherapeutic Treatments
NCT07856745 is registered in ClinicalTrials.gov with Portal Access Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-arm Study Evaluating the Efficacy and Safety of FLEXIPORT, a Single-incision Totally Implantable Venous Access Device, in Patients Receiving Chemotherapeutic Treatments
- Lead sponsor
- Portal Access Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2024
- Completion date
- February 24, 2026
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.